InvestorsHub Logo
Followers 20
Posts 456
Boards Moderated 0
Alias Born 10/27/2012

Re: Tim501 post# 99

Thursday, 09/15/2016 4:33:48 PM

Thursday, September 15, 2016 4:33:48 PM

Post# of 138
Indeed, if you are looking into this investment, the Call is a must.

What is intriguing is that there is Stem Cell fatigue with investors: so many failed clinically of diluted shareholders to oblivion very few bother to follow the sector.

The science is working out and the story is being derisked.

I believe that we are not very far from inflection point in public perception: Stem Cell therapy - validated in the clinic- is going to get high valuations.